NCT00053924View on ClinicalTrials.gov

Perifosine in Treating Patients With Advanced Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2003

Primary Completion Date

May 31, 2006

Conditions
Pancreatic Cancer
Interventions
DRUG

perifosine

Trial Locations (3)

L8V 5C2

Margaret and Charles Juravinski Cancer Centre, Hamilton

N6A 4L6

Cancer Care Ontario-London Regional Cancer Centre, London

M5G 2M9

Princess Margaret Hospital, Toronto

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University Health Network, Toronto

OTHER

NCT00053924 - Perifosine in Treating Patients With Advanced Pancreatic Cancer | Biotech Hunter | Biotech Hunter